These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.
    Author: Griffin K, Bedford R, Townson K, Phillpotts R, Funnell S, Morton M, Williamson D, Titball R.
    Journal: FEMS Immunol Med Microbiol; 2005 Mar 01; 43(3):425-30. PubMed ID: 15708318.
    Abstract:
    Vaccines against bioterrorism agents offer the prospect of providing high levels of protection against airborne pathogens. However, the diversity of the bioterrorism threat means that it may be necessary to use several vaccines simultaneously. In this study we have investigated whether there are changes to the protective immune response to a recombinant sub-unit plague vaccine when it is co-administered with other sub-unit or live attenuated vaccines. Our results indicate that the co-administration of these vaccines did not influence the protection afforded by the plague vaccine. However, the co-administration of the plague sub-unit vaccine with a live vaccine resulted in markedly increased levels of IgG2a subclass antibodies, and markedly reduced levels of IgG1 subclass antibodies, to the plague sub-unit vaccine. This finding might have implications when considering the co-administration of other vaccine combinations.
    [Abstract] [Full Text] [Related] [New Search]